Northeast Investment Management Sells 44,500 Shares of Kenvue Inc. (NYSE:KVUE)

Northeast Investment Management lowered its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 51.6% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 41,663 shares of the company's stock after selling 44,500 shares during the period. Northeast Investment Management's holdings in Kenvue were worth $999,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of KVUE. SRS Capital Advisors Inc. lifted its position in shares of Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after buying an additional 571 shares in the last quarter. Asset Planning Inc bought a new position in shares of Kenvue during the 4th quarter worth approximately $42,000. Clarity Asset Management Inc. bought a new position in shares of Kenvue during the 4th quarter worth approximately $45,000. SBI Securities Co. Ltd. bought a new position in shares of Kenvue during the 4th quarter worth approximately $46,000. Finally, Deseret Mutual Benefit Administrators lifted its position in shares of Kenvue by 29.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock worth $54,000 after buying an additional 568 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

KVUE has been the topic of a number of research reports. Citigroup lifted their price target on shares of Kenvue from $22.00 to $24.50 and gave the stock a "neutral" rating in a report on Friday, May 9th. Evercore ISI initiated coverage on shares of Kenvue in a report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price target on the stock. Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. Canaccord Genuity Group lifted their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a report on Wednesday, March 5th. Finally, Barclays lifted their price target on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a report on Monday, May 12th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $25.33.

Kenvue Stock Performance

KVUE stock traded up $0.20 during midday trading on Thursday, reaching $22.05. 28,056,295 shares of the company's stock traded hands, compared to its average volume of 16,395,431. The company has a 50-day moving average price of $23.02 and a two-hundred day moving average price of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17. The firm has a market capitalization of $42.31 billion, a PE ratio of 41.60, a price-to-earnings-growth ratio of 2.62 and a beta of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The business had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.69 billion. During the same quarter in the previous year, the firm posted $0.28 EPS. The business's revenue for the quarter was down 3.9% compared to the same quarter last year. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were issued a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.72%. Kenvue's payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.